{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:25:40Z","timestamp":1790115940374,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":923,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"A. Menarini Industrie Farmaceutiche Riunite"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jacep.2015.02.019","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T15:15:08Z","timestamp":1437491708000},"page":"326-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Age-Related Differences in Presentation, Treatment, and Outcome of Patients With\u00a0Atrial Fibrillation in Europe"],"prefix":"10.1016","volume":"1","author":[{"given":"Stefano","family":"Fumagalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah A.M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Gabbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea Ioachim","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Hvilsted","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2015.02.019_bib1","first-page":"e28","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.02.019_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.02.019_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2015.02.019_bib4","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2015.02.019_bib5","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2015.02.019_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.02.019_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2009.04.035","article-title":"Predictive factors for all-cause mortality in the\u00a0hospitalized elderly subject: the importance\u00a0of\u00a0arrhythmia","volume":"207","author":"Vesin","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacep.2015.02.019_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/01.wnl.0000341280.31919.bd","article-title":"Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006","volume":"72","author":"Bejot","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jacep.2015.02.019_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.111.962688","article-title":"Atrial fibrillation and mortality in heart failure: a community study","volume":"4","author":"Chamberlain","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacep.2015.02.019_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.0b013e31829a33d1","article-title":"Atrial fibrillation and cognitive decline: a longitudinal cohort study","volume":"81","author":"Thacker","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jacep.2015.02.019_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacep.2015.02.019_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2015.02.019_bib13","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial\u00a0fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2015.02.019_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF03654822","article-title":"Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation","volume":"24","author":"Fumagalli","year":"2012","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jacep.2015.02.019_bib15","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.ijcard.2012.07.019","article-title":"Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study","volume":"167","author":"Di Pasquale","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2015.02.019_bib16","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.02.019_bib17","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1253\/circj.CJ-13-0465","article-title":"Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation: focus on the elderly","volume":"77","author":"Lip","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jacep.2015.02.019_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation\u2013developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2015.02.019_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A\u00a0prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2015.02.019_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/europace\/eup421","article-title":"Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation","volume":"12","author":"Arribas","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2015.02.019_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.02.019_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1524-4733.2006.00124.x","article-title":"Assessing the direct\u00a0costs of treating nonvalvular atrial fibrillation in the United States","volume":"9","author":"Coyne","year":"2006","journal-title":"Value Health"},{"key":"10.1016\/j.jacep.2015.02.019_bib23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2009.04.091","article-title":"Quality of care for atrial fibrillation among patients hospitalized for heart failure","volume":"54","author":"Piccini","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.02.019_bib24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.amjmed.2013.04.021","article-title":"Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation","volume":"126","author":"Shariff","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2015.02.019_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jacc.2004.06.041","volume":"44","author":"McNamara","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.02.019_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/intqhc\/mzi026","article-title":"Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission","volume":"17","author":"Lim","year":"2005","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacep.2015.02.019_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjmed.2013.01.037","article-title":"Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation","volume":"126","author":"Hess","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2015.02.019_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.10-2436","article-title":"Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project","volume":"140","author":"Gorin","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jacep.2015.02.019_bib29","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis","volume":"288","author":"van Walraven","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2015.02.019_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.110.007864","article-title":"Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation","volume":"124","author":"Poli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.02.019_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/afl129","article-title":"A\u00a0randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacep.2015.02.019_bib32","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","article-title":"Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)","volume":"27","author":"Friberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2015.02.019_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11319540-000000000-00000","article-title":"Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study","volume":"27","author":"Tulner","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jacep.2015.02.019_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2015.02.019_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.amjmed.2012.10.012","article-title":"New oral anticoagulants in elderly patients with atrial fibrillation","volume":"126","author":"Deedwania","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2015.02.019_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jgs.12799","article-title":"New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials","volume":"62","author":"Sardar","year":"2014","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jacep.2015.02.019_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF03324785","article-title":"Atrial fibrillation is a possible marker of frailty in hospitalized patients: results of the GIFA Study","volume":"22","author":"Fumagalli","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jacep.2015.02.019_bib38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/bmj.319.7221.1353","article-title":"Ageism in cardiology","volume":"319","author":"Bowling","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacep.2015.02.019_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2011.01.078","article-title":"Device therapy in patients with heart failure and advanced age: too much too late?","volume":"155","author":"Cutro","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2015.02.019_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/ageing\/24.6.461","article-title":"Evidence-based and evidence-biased medicine","volume":"24","author":"Evans","year":"1995","journal-title":"Age Ageing"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X15000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X15000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:34:06Z","timestamp":1762500846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X15000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2405500X15000936"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2015.02.019","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-Related Differences in Presentation, Treatment, and Outcome of Patients With\u00a0Atrial Fibrillation in Europe","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2015.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}